Ignite Creation Date:
2024-07-17 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495281
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
Observational Study of Triple Combination Therapy of Zemidapa Tab and Metformin in Type 2 Diabetes Mellitus Patients
Sponsor:
LG Chem
Organization:
LG Chem
Organization Data
Organization:
LG Chem
Class:
INDUSTRY
Study ID:
LG-GLOS001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LG Chem
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None